Wealthfront Advisers LLC Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

Wealthfront Advisers LLC bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 107,390,188 shares of the company’s stock, valued at approximately $10,304,089,000. HealthEquity accounts for 8.5% of Wealthfront Advisers LLC’s investment portfolio, making the stock its 3rd biggest holding. Wealthfront Advisers LLC owned approximately 123.92% of HealthEquity as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $2,322,000 after acquiring an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after acquiring an additional 100 shares during the last quarter. State of Michigan Retirement System boosted its position in HealthEquity by 0.5% during the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock worth $1,988,000 after acquiring an additional 100 shares during the last quarter. Finally, Raymond James Trust N.A. boosted its position in HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after acquiring an additional 132 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $94.48 on Tuesday. The company’s 50 day simple moving average is $105.80 and its 200-day simple moving average is $94.66. The company has a market capitalization of $8.19 billion, a price-to-earnings ratio of 86.68, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the previous year, the company earned $0.40 earnings per share. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Buying and Selling

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on HQY. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. JMP Securities lifted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research note on Tuesday, December 10th. Raymond James lifted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Finally, Bank of America lifted their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and a consensus price target of $113.54.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.